Trade Summary

4 days ago, Turner William D., serving as Chief Regulatory Officer at Vera Therapeutics, Inc. (VERA), sold 2,187 shares at $41.98 per share, for a total transaction value of $91,819.00. Following this transaction, Turner William D. now holds 45,313 shares of VERA.

This sale represents a 5.00% decrease in Turner William D.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.